FDA issues guidance on conducting remote interactive evaluations during the COVID-19 pandemic
By EsqSocial Corporation 15/04/21
On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency,” ......
By: Hogan Lovells